Where the Money Goes

You are here

ALSF Childhood Cancer Research Grants

With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.

Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.

You can learn about ALSF's grant review process here.

Support This Research

Jump to search filters

ALSF Funded Research Projects

Project Title	Institution / Principal Investigator(s)	Grant Type	Year	State
Mechanisms of CNOT3 Tumor Suppression in T-ALL and Identification of New Drugs That Specifically Kill CNOT3-Deficient T-ALL Cells	Dana-Farber Cancer Institute / Zhaodong Li, PhD	Young Investigator Grants	2014	Massachusetts
Correction of Hematopoietic Defects in Down Syndrome by Chromosome 21 Silencing	University of Massachusetts Medical School / Peter Newburger, M.D.	Innovation Grants	2014	Massachusetts
Development of a Screening Module to Assess Sibling-Related Psychosocial Risk in Families of Children with Cancer	Boston University / Kristin Long, PhD	Psychosocial Grants	2014	Massachusetts
Understanding and Preventing Healthy Tissue Damage in Pediatric Cancer Patients	Dana-Farber Cancer Institute / Kristopher Sarosiek, PhD	Young Investigator Grants	2014	Massachusetts
Translating BET Bromodomain Inhibitors for Acute Myeloid Leukemia Therapy	Dana-Farber Cancer Institute / Yana Pikman, MD	Young Investigator Grants	2014	Massachusetts
Role of LMO1 in Neuroblastoma Initiation and Maintenance: Analysis in the Zebrafish model of Childhood Neuroblastoma	Dana-Farber Cancer Institute / Thomas Look, M.D.	Innovation Grants	2014	Massachusetts
Modeling the Multi-hit Pathogenesis of t(12;21) Associated Pediatric ALL by CRISPR/Cas-mediated Genome Engineering	Massachusetts General Hospital / Hanno Hock, M.D., Ph.D.	Innovation Grants	2014	Massachusetts
Development of Targeted Leukemia Inhibitors Using Nanoparticle Delivery	University of Massachusetts Medical School / Lucio Castilla, Ph.D.	Innovation Grants	2014	Massachusetts
SETD2 Mutations in Prognosis and Chemotherapy Resistance in Relapsed Acute Lymphoblastic Leukemia	Dana-Farber Cancer Institute / Brenton Mar, MD, PhD	Young Investigator Grants	2014	Massachusetts
A Developmental Model to Characterize the Epigenetic Origins of the Retinoblastoma Tumor Initiating Cell	The Johns Hopkins University School of Medicine / Jeffrey Huo, MD, PhD	Young Investigator Grants	2014	Maryland

Pages